US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

28.69

-0.2801-0.97%

Volume:107

Turnover:3K

Market Cap:1.00M

PE:- -

High:28.69

Open:28.97

Low:28.69

Close:28.97

52wk High:29.88

52wk Low:24.32

Shares:35.00K

Float Shares:35.00K

Volume Ratio:0.14

T/O Rate:0.31%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

Ulta Beauty Stock Falls After Upbeat Earnings

Deals of the Day-Mergers and Acquisitions

Kimberly-Clark Files for EU Antitrust Approval of Kenvue Takeover

MT Newswires Live

Argus Raises Estee Lauder Price Target to $125 From $100

MT Newswires Live

Preview: Ulta's Q2 EPS, Rev Seen Rising but Shares Slip

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS

Ulta Beauty Earnings are Coming After an Ugly Stock Selloff

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

Kenvue Says Kenvue Cares Week Volunteer Program Logs 7,750 Hours in 2026 Healthy Lives Mission Report

Gubra Earns USD 50 Million Milestone as AbbVie Starts Phase 2 Trial of Obesity Drug ABBV-295

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

How GLP-1 Sales Could Play Out for Hims & Hers

Analysts Offer Insights on Consumer Goods Companies: The Estée Lauder Companies (EL) and Simply Good Foods (SMPL)

Estée Lauder Exec VP, General Counsel Rashida La Lande Sells 5,564 Shares for $553,695.4

China's Shandong Xinhua Profit Drops on Domestic, International Competition

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/GLAM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":28.6876,"timestamp":1788292800000,"preClose":28.9677,"halted":0,"volume":107,"delay":0,"changeRate":-0.00966939038998612,"floatShares":35000,"shares":35000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.2801,"latestTime":"09-02 04:14:03 EDT","open":28.9677,"high":28.6876,"low":28.6876,"amount":3110,"amplitude":0,"askPrice":45.61,"askSize":100,"bidPrice":11.54,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"exchange":"CBOE","adjPreClose":28.6876,"nav":28.95,"aum":1013250,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.9677,"preClose":28.6876,"latestTime":"16:10 EDT","volume":4,"amount":114.7504,"timestamp":1788293404266,"change":0.2801,"changeRate":0.009764,"amplitude":0},"volumeRatio":0.1354773497571385,"impliedVol":0.3718,"impliedVolPercentile":0.1507},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":35000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.1354773497571385,"shares":35000,"dividePrice":0,"high":28.6876,"amplitude":0,"preClose":28.9677,"low":28.6876,"week52Low":24.3178,"pbRate":"--","week52High":29.88,"institutionHeld":0,"latestPrice":28.6876,"eps":0,"divideRate":0,"volume":107,"delay":0,"ttmEps":0,"open":28.9677,"prevYearClose":25.82,"prevWeekClose":28.8664,"prevMonthClose":28.9677,"prevQuarterClose":27.6454,"fiveDayClose":29.1184,"twentyDayClose":28.8134,"sixtyDayClose":24.8649},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663015390","title":"AbbVie Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015390","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015390?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:32","pubTimestamp":1787949120,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  slipped 1.03% to $255.48 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.This was the stock's third consecutive day of losses.AbbVie Inc. closed 4.48% below its 52-week high of $267.47, which the company achieved on July 29th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Amgen Inc.  fell 1.05% to $432.42.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","LU2129689431.USD","LU1989772840.SGD","IE0000B7K699.USD","LU0170899867.USD","LU0128525929.USD","LU1023059063.AUD","LU0861579265.USD","LU1267930573.SGD","PJP","SG9999015978.USD","LU1670627923.USD","LU1037948897.HKD","LU0289739699.SGD","LU0868494617.USD","IE00B2B36J28.USD","LU0820561909.HKD","LU2023251221.USD","LU0726765562.USD","JDOC","LU2357627491.SGD","LU1037948541.HKD","SG9999015945.SGD","IXJ","IE000BZT7R73.USD","LU0203345920.USD","LU1839511570.USD","LU1989772923.USD","LU2112291526.USD","SG9999001440.SGD","LU0114720955.EUR","LU0472753341.HKD","LU1061106388.HKD","LU1093756325.SGD","VHT","LU0069063385.USD","SG9999003800.SGD","IE00B4R5TH58.HKD","IE00BVYPNW00.USD","SG9999015952.SGD","IE00BN8TJ469.HKD","BK4550","LU2433249047.HKD","LU2237443978.SGD","LU2089283258.USD","LU2237443382.USD","LU0661504455.SGD","LU0456855351.SGD","LU1291159041.SGD","LU0949170772.SGD","LU1732800096.USD","LU0417517546.SGD","LU0965509101.SGD","TRUH","LU0882574055.USD","XLV","LU0943347566.SGD","LU1670628061.USD","BK4559","FTXH","IE00B3PB1722.GBP","LU2133065610.SGD","IE0009355771.USD","IE00B42XCP33.USD","LU0395794307.EUR","IE00B19Z3581.USD","LU0965508806.USD","RXL","LU0234570918.USD","LU0823416689.USD","BK4585","LU1496350171.SGD","BK4581","LU2087621335.USD","LU2237443895.HKD","LU0545039389.USD","LU0511384066.AUD","LU2089284900.SGD","LU2125909593.SGD","LU2237443549.SGD","IE00BDGV0183.EUR","LU0122379950.USD","IE000WAW04H5.SGD","LU0234572021.USD","LU0795875169.SGD","LU1551013425.SGD","LU1585245621.USD","LU1983299246.USD","LU1003077747.HKD","LU1989771016.USD","LU0098860793.USD","LU2125909247.SGD","LU0708994859.HKD","LU0859254822.USD","IE00BVYPNV92.GBP","LU0795875086.SGD","LU1923622614.USD","IE00B19Z3B42.SGD","LU0289739343.SGD","IE0002141913.USD","LU2237443622.USD","LU0057025933.USD","SG9999015986.USD","LU1057294990.SGD","FHLC","LU0158827948.USD","LU1718418525.SGD","IE000SO60NU8.SGD","LU0942090050.USD","LU1074936037.SGD","BK4533","LU1162221912.USD","LU1496350502.SGD","BK4139","LU1244550494.USD","LU0868494708.USD","LU1551013342.USD","LU0198837287.USD","IE00BLSP4239.USD","LU0256863811.USD","LU0738911758.USD","IE000F7OJYX1.SGD","LU1093756168.USD","LU1236620750.USD","LU0058720904.USD","LU0124676726.USD","LU1934455194.USD","LU0553294199.USD","LU0912757837.SGD","LU1244550221.USD","LU2237443465.HKD","IE00BBT3K403.USD","LU1732799900.SGD","LU0211328371.USD","LU1236620834.HKD","LU1267930490.SGD","LU2347655073.USD","AGNG","SG9999011175.SGD","BK4566","LU0203347892.USD","LU2347655156.SGD","LU0310800379.SGD","IE00BJJMRZ35.SGD","LU0965509010.AUD","IE0002270589.USD","IYH","LU0211327993.USD","LU0432979614.USD","LU1430594728.SGD","LU0689472784.USD","IE00BJT1NW94.SGD","LU2129689514.USD","LU0029864427.USD","IE00BFTCPJ56.SGD","GLAM","LU0310799852.SGD","LU0689626769.HKD","BK4588","IE0004445239.USD","LU0256863902.USD","IE00BSNM7G36.USD","LU0320765646.SGD","MEDX","LU2468319806.SGD","LU1934455277.USD","LU2089984988.USD","PPH","LU1929549753.HKD","IE000MB6IJN5.SGD","BK4534","LU2129689605.HKD","LU0820561818.USD","ABBV","IE00BGHQF631.EUR","LU0985320562.USD","LU1934455863.HKD","LU0289961442.SGD","IE00BLSP4452.SGD","LU1244550577.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663009747","title":"AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2663009747","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663009747?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:31","pubTimestamp":1787934678,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has posted a new Phase 3 trial plan for its drug etentamig in amy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-rare-blood-disorder-with-new-phase-3-etentamig-trial-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-rare-blood-disorder-with-new-phase-3-etentamig-trial-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4585","RXL","LU2129689431.USD","IE00BLSP4239.USD","SG9999011175.SGD","LU0942090050.USD","IE00BBT3K403.USD","IE00BSNM7G36.USD","LU0868494708.USD","IE000BZT7R73.USD","LU1244550494.USD","ABBV","AGNG","BK4550","IE0004445239.USD","LU2237443465.HKD","PJP","IE0000B7K699.USD","MEDX","PSIL","IYH","LU1074936037.SGD","LU0795875169.SGD","JDOC","LU2089283258.USD","LU1496350171.SGD","TRUH","IE00B42XCP33.USD","FTXH","IE000SO60NU8.SGD","FHLC","BBC","LU1496350502.SGD","GLAM","LU1267930490.SGD","LU1670627923.USD","LU0320765646.SGD","IE0002141913.USD","IE00B2B36J28.USD","IXJ","VHT","LU1989772840.SGD","PPH","LU0985320562.USD","LU1934455194.USD","LU2112291526.USD","LU0029864427.USD","LU0057025933.USD","LU0726765562.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069444","title":"Ulta Beauty Stock Falls After Upbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069444","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662069444?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:08","pubTimestamp":1787911680,"startTime":"0","endTime":"0","summary":"Ulta Beauty's shares have been more like an eyesore this year and they were falling in the Friday premarket. But the stock initially rose late Thursday, reflecting investors' initial positive reaction to its upbeat results.Ulta said it earned $6.55 a share in its fiscal second quarter, on revenue that rose nearly 9% year over year, to $3.04 billion. Analysts were looking for earnings per share of $6.20 on revenue of $2.99 billion.Comparable sales were up 3.8% in the quarter.For the full year, the company now expects to earn between $28.70 and $29, up from its prior forecast of $28.36 to $28.80. It sees revenue growth of 6.7% to 7.2%, which translates to $13.22 billion to $13.28 billion. Consensus calls for full-year earnings per share of $28.80 and revenue of $13.25 billion.The shares were down 1.5% in the Friday premarket having risen 1% just after the report.The news comes after last week's great quarter from prestige beauty company Estée Lauder.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ULTA","BK4558","BK4114","GLAM","LU1064131342.USD","LU0823411888.USD","LU1244550221.USD","LU0211327993.USD","BK4585","LU0052756011.USD","LU0310800965.SGD","LU2552382058.USD","BK4596","TGT","BK4200","LU0310799852.SGD","LU1169590202.USD","LU1988902786.USD","LU2237443622.USD","LU0211328371.USD","BK4597","LU1267930490.SGD","LU0128525689.USD","LU2404859741.USD","LU0690374961.EUR","BK4155","LU0690374615.EUR","EL","LU2404859667.USD","LU2552382215.SGD","LU2237443549.SGD","BK4183","LU2237443978.SGD","LU1244550494.USD","LU1169589451.USD","LU1267930227.SGD","LU2264538146.SGD","BK4533","BK4548","BK4532","BK4588","LU2237443382.USD","LU2552382132.HKD","LU1244550577.SGD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662617066","title":"Deals of the Day-Mergers and Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2662617066","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662617066?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:50","pubTimestamp":1787910624,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsAugust 28 (Reuters)-The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Friday:** BertelsmannBTGGg.Fcould complete one or two ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL6N44P0IC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003077747.HKD","LU0738911758.USD","LU0321505439.SGD","LU0368265418.SGD","LU0203347892.USD","LU2023250504.SGD","LU0289960550.SGD","LU0266512127.USD","LU0987226296.USD","LU0211327993.USD","LU0784384876.USD","LU2125154778.USD","BTGO","LU1098665638.USD","LU2089283258.USD","LU2125154935.USD","SG9999002521.SGD","LU0068578508.USD","LU0965509101.SGD","LU1064927863.SGD","ESI","LU0757428866.USD","LU1242518857.USD","KVUE","LU0310799852.SGD","BK4018","LU0630314457.HKD","LU0965509010.AUD","SOLS","BK4127","LU0211328371.USD","LU0345781412.USD","GLAM","BK4585","BK4109","LU1035777561.USD","LU1267930227.SGD","LU1267930573.SGD","IE00BFXG1179.USD","LU1069347547.HKD","SG9999001440.SGD","LU0661504455.SGD","PSCM","LU1019634622.SGD","LU2360032135.SGD","RSPS","LU0545039389.USD","SHEL.UK","LU0788109394.HKD","KMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662050049","title":"Kimberly-Clark Files for EU Antitrust Approval of Kenvue Takeover","url":"https://stock-news.laohu8.com/highlight/detail?id=2662050049","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662050049?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:41","pubTimestamp":1787906511,"startTime":"0","endTime":"0","summary":"Kimberly-Clark  has asked EU regulators to clear its proposed acquisition of Kenvue , according to a filing published Thursday on the European Commission's website.The deal, announced in November 2025, values Kenvue at an enterprise value of $48.7 billion and is expected to close in H2.The transaction would see Kimberly-Clark acquire all outstanding common shares of Kenvue under the 2025 agreement.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RSPS","KVUE","LU1430594728.SGD","LU1585245621.USD","BK4183","SG9999001440.SGD","LU1267930573.SGD","LU0310800379.SGD","LU0128525929.USD","BK4504","BK4585","BK4018","BK4588","GLAM","BK4567","LU0708994859.HKD","IE00BFXG1179.USD","LU2463526074.USD","KMB","LU0889566641.SGD","LU1571399168.USD","LU1267930813.SGD","LU0792757196.USD","IE00B3T34201.USD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662087297","title":"Argus Raises Estee Lauder Price Target to $125 From $100","url":"https://stock-news.laohu8.com/highlight/detail?id=2662087297","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662087297?lang=en_us&edition=fundamental","pubTime":"2026-08-28 02:49","pubTimestamp":1787856543,"startTime":"0","endTime":"0","summary":"Estee Lauder (EL) has an average rating of overweight and mean price target of $107.90, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1064131342.USD","EL","LU0690374961.EUR","LU2552382058.USD","LU2552382132.HKD","LU2404859741.USD","LU2552382215.SGD","BK4504","BK4588","BK4585","GLAM","LU0690374615.EUR","LU2404859667.USD","LU1988902786.USD","BK4533","BK4548","LU2264538146.SGD","BK4558","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662082945","title":"Preview: Ulta's Q2 EPS, Rev Seen Rising but Shares Slip","url":"https://stock-news.laohu8.com/highlight/detail?id=2662082945","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662082945?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:32","pubTimestamp":1787851978,"startTime":"0","endTime":"0","summary":"BUZZ-PREVIEW: Ulta's Q2 EPS, rev seen rising but shares slip** Shares in cosmetics retailer Ulta BeautyULTA.Odown 2.1% on Thursday ahead of fiscal Q2 report due after market close** Wall Street sees U","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL6N44O11W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382215.SGD","LU1242518931.SGD","COTY","LU2404859667.USD","BK4585","LU0690374961.EUR","BK4504","ULTA","LU0690374615.EUR","BK4548","EL","IE00B19Z3B42.SGD","LU2552382132.HKD","IE0002270589.USD","ELF","LU0823411888.USD","LU1064131342.USD","LU1169589451.USD","BK4533","BK4200","LU2264538146.SGD","LU2404859741.USD","LU1242518857.USD","IE00B19Z3581.USD","LU1988902786.USD","BK4183","LU2552382058.USD","LU0979878070.USD","BK4588","BK4558","LU0566484027.USD","GLAM","LU1169590202.USD","LU1559883803.SGD","LU0053671581.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662108530","title":"China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2662108530","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662108530?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:10","pubTimestamp":1787839834,"startTime":"0","endTime":"0","summary":"China's HBM Holdings H1 revenue rises on progress on mid-late clinical stage programsOverviewChina biopharma firm's half-year revenue rose yr/yr to $122.5 mlnNet profit for the period declined compare","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","ABBV","LU2237443465.HKD","LU0708994859.HKD","TRUH","LU0061475181.USD","IE000BZT7R73.USD","IHE","LU1037948541.HKD","FHLC","BK4007","FTXH","PPH","LU1718418525.SGD","02616","BMY","LU0225771236.USD","JDOC","LU0661504455.SGD","RXL","GLAM","LU0237698245.USD","LU0985320562.USD","SG9999015952.SGD","IXJ","LU1057294990.SGD","XLV","BK1161","MEDX","LU1267930573.SGD","LU0868494708.USD","LU0289739343.SGD","02142","LU1670711123.USD","VHT","BK4588","LU0310800379.SGD","LU1989771016.USD","LU1868836591.USD","AGNG","688331","IE00BVYPNW00.USD","IE0000B7K699.USD","LU0057025933.USD","PJP","LU0256863811.USD","IYH","LU2237443622.USD","LU2125154935.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708043","title":"China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708043","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708043?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:08","pubTimestamp":1787825320,"startTime":"0","endTime":"0","summary":"China's JW Therapeutics interim revenue rises 4.7% on Carteyva salesOverviewChina cell immunotherapy developer's interim revenue grew 4.7% yr/yr, driven by Carteyva salesGross profit margin improved t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABBV","LU0395794307.EUR","BBH","LU0463099449.HKD","IBB","IBBQ","IE0004445239.USD","LU1934455277.USD","LU2237443382.USD","LU2237443978.SGD","LU2097828714.EUR","XLV","MEDX","LU1037948897.HKD","RXL","IE00BVYPNV92.GBP","02126","LU0868494617.USD","LU1934455863.HKD","IE000SO60NU8.SGD","IYH","IE00BN8TJ469.HKD","REGN","TRUH","FHLC","PJP","LU0859254822.USD","FTXH","LU1188198961.HKD","LU0310799852.SGD","CMI","AGNG","PPH","TBXU","LU0949170772.SGD","BK1574","GLAM","LU0943347566.SGD","VHT","688331","KURE","LU2362541513.USD","LU0708994859.HKD","MADE","LU1244550577.SGD","03692","01801","IXJ","JDOC","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662733417","title":"AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733417","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662733417?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:01","pubTimestamp":1787810517,"startTime":"0","endTime":"0","summary":"AbbVie seeks EMA approval for Skyrizi subcutaneous induction in Crohn’s diseaseAbbVie filed with the EMA seeking approval for SKYRIZI subcutaneous induction in adults with moderately to severely activ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL4xK88y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0417517546.SGD","LU0965509010.AUD","LU1989771016.USD","LU2433249047.HKD","LU2087621335.USD","PPH","IE00BGHQF631.EUR","LU0203347892.USD","RXL","PJP","LU2129689514.USD","LU2023251221.USD","VHT","LU0472753341.HKD","LU1244550221.USD","MEDX","LU1496350502.SGD","LU1093756325.SGD","LU1037948897.HKD","LU1003077747.HKD","BK4559","SG9999001440.SGD","FTXH","IYH","LU2237443895.HKD","SG9999011175.SGD","LU0861579265.USD","LU1670628061.USD","JDOC","XLV","TRUH","GLAM","IE0002270589.USD","LU1718418525.SGD","SG9999015945.SGD","LU2468319806.SGD","LU0708994859.HKD","LU1934455863.HKD","FHLC","LU0882574055.USD","ABBV","LU1923622614.USD","AGNG","IE00BFTCPJ56.SGD","LU0198837287.USD","LU1934455277.USD","LU0320765646.SGD","IXJ","LU1236620834.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778703","title":"Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778703?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUAC1ZNZW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1989772840.SGD","LU0256863902.USD","AGNG","LU0256863811.USD","LU0289739343.SGD","LU0158827948.USD","BK4139","JDOC","IXJ","LU2237443895.HKD","FHLC","FTXH","MEDX","VHT","PJP","GLAM","SG9999003800.SGD","XLV","LU0098860793.USD","LU1551013342.USD","LU1585245621.USD","LU1670628061.USD","LU2089283258.USD","PPH","LU2129689514.USD","LU1267930490.SGD","LU1267930573.SGD","LU1244550221.USD","LU1236620834.HKD","LU1244550494.USD","LU2468319806.SGD","IE0004445239.USD","LU1162221912.USD","LU0795875086.SGD","LU0965508806.USD","BK4550","LU0511384066.AUD","IE00BVYPNW00.USD","LU0310799852.SGD","LU0985320562.USD","ABBV","LU0912757837.SGD","LU0949170772.SGD","LU1244550577.SGD","LU0795875169.SGD","IYH","LU0203345920.USD","LU1989771016.USD","TRUH","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662309773","title":"Ulta Beauty Earnings are Coming After an Ugly Stock Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2662309773","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662309773?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810400,"startTime":"0","endTime":"0","summary":"Ulta Beauty's shares have been more like an eyesore this year.Consensus calls for Ulta to earn $6.21 a share on revenue of $3 billion when it reports results on Thursday. The shares sold off after the","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2264538146.SGD","LU2404859667.USD","LU1169589451.USD","LU1169590202.USD","LU2237443978.SGD","BK4533","BK4532","LU0128525689.USD","GLAM","LU0310800965.SGD","LU1244550577.SGD","LU2552382132.HKD","LU0690374961.EUR","LU1267930227.SGD","LU0823411888.USD","BK4596","LU2237443622.USD","LU2404859741.USD","LU2237443549.SGD","BK4504","BK4183","EL","LU1267930490.SGD","LU2237443382.USD","ULTA","BK4200","LU0211328371.USD","LU0211327993.USD","LU1064131342.USD","LU1988902786.USD","LU2552382058.USD","LU0310799852.SGD","BK4114","BK4597","BK4155","LU0052756011.USD","BK4548","BK4558","BK4585","LU1244550494.USD","BK4588","TGT","LU2552382215.SGD","LU0690374615.EUR","LU1244550221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662274470","title":"AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2662274470","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662274470?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:32","pubTimestamp":1787776320,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  slid 1.09% to $262.90 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.02% to 7,675.70 and Dow Jones Industrial Average  falling 0.21% to 53,463.88.AbbVie Inc. closed 1.71% short of its 52-week high of $267.47, which the company achieved on July 29th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 1.15% to $270.00, Pfizer Inc.  fell 0.95% to $28.30, and Amgen Inc.  fell 0.43% to $440.34.Trading volume  remained 3.8 million below its 50-day average volume of 7.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0553294199.USD","LU2237443549.SGD","XLV","IE0004445239.USD","IE00BVYPNW00.USD","LU1236620834.HKD","LU0289739343.SGD","BK4585","LU0689472784.USD","SG9999015986.USD","LU0057025933.USD","BK4139","LU1989771016.USD","IE00BVYPNV92.GBP","LU1983299246.USD","LU0069063385.USD","LU1718418525.SGD","IE00B19Z3B42.SGD","SG9999015978.USD","LU2125909593.SGD","LU0203345920.USD","LU1023059063.AUD","LU1989772840.SGD","IYH","LU2089284900.SGD","LU2237443382.USD","LU0511384066.AUD","PPH","LU1244550494.USD","LU1037948541.HKD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","LU0234572021.USD","LU0122379950.USD","LU0795875086.SGD","LU1003077747.HKD","IE0000B7K699.USD","LU0395794307.EUR","MEDX","LU0170899867.USD","LU0726765562.USD","LU1934455863.HKD","FHLC","LU1732800096.USD","LU1929549753.HKD","IE000F7OJYX1.SGD","BK4588","SG9999003800.SGD","LU0114720955.EUR","LU0124676726.USD","LU0320765646.SGD","LU0417517546.SGD","BK4533","LU2125909247.SGD","AGNG","LU0234570918.USD","LU2129689605.HKD","IE00BSNM7G36.USD","IE0002141913.USD","LU0965509283.SGD","LU1670628061.USD","LU2433249047.HKD","LU1934455194.USD","LU1989772923.USD","IE00BJT1NW94.SGD","SG9999015952.SGD","LU0456855351.SGD","FTXH","IE00BN8TJ469.HKD","LU2089984988.USD","LU0820561818.USD","LU1291159041.SGD","LU0432979614.USD","LU1430594728.SGD","LU2129689431.USD","LU0098860793.USD","LU0823416689.USD","LU0545039389.USD","GLAM","LU1244550221.USD","IE00BFTCPJ56.SGD","LU1267930573.SGD","IE00B19Z3581.USD","LU2112291526.USD","LU1037948897.HKD","LU0942090050.USD","LU0029864427.USD","BK4550","LU0661504455.SGD","LU1236620750.USD","IE000MB6IJN5.SGD","IE00B3PB1722.GBP","LU0289739699.SGD","LU1496350171.SGD","LU0882574055.USD","LU1839511570.USD","IE000BZT7R73.USD","LU0058720904.USD","LU1732799900.SGD","SG9999001440.SGD","LU1670627923.USD","LU0689626769.HKD","LU0820561909.HKD","LU0985320562.USD","LU0256863811.USD","LU0158827948.USD","LU1496350502.SGD","LU1551013342.USD","JDOC","LU2237443622.USD","LU0868494708.USD","IE00BDGV0183.EUR","LU1093756325.SGD","LU0211328371.USD","LU1551013425.SGD","LU1244550577.SGD","RXL","LU1162221912.USD","BK4559","BK4566","IE00BGHQF631.EUR","SG9999015945.SGD","LU0861579265.USD","IE00BLSP4239.USD","LU0868494617.USD","LU1934455277.USD","LU2237443465.HKD","LU1057294990.SGD","TRUH","LU2347655156.SGD","LU0310800379.SGD","IE00B2B36J28.USD","LU0949170772.SGD","LU0203347892.USD","LU0289961442.SGD","LU0859254822.USD","LU1267930490.SGD","LU0943347566.SGD","LU2129689514.USD","LU1093756168.USD","LU2023251221.USD","LU2237443895.HKD","SG9999011175.SGD","LU0310799852.SGD","VHT","BK4581","LU0965509101.SGD","IE0002270589.USD","IE00B42XCP33.USD","LU0472753341.HKD","LU0912757837.SGD","LU1585245621.USD","PJP","IE00B4R5TH58.HKD","IE00BBT3K403.USD","LU0256863902.USD","LU1923622614.USD","LU0795875169.SGD","LU0965509010.AUD","LU1074936037.SGD","LU2237443978.SGD","LU1061106388.HKD","IE0009355771.USD","LU0708994859.HKD","ABBV","LU0738911758.USD","LU0198837287.USD","LU2347655073.USD","LU2357627491.SGD","LU0211327993.USD","LU0965508806.USD","LU2468319806.SGD","IXJ","LU2133065610.SGD","BK4534","LU2087621335.USD","IE00BJJMRZ35.SGD","LU2089283258.USD","IE00BLSP4452.SGD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662482227","title":"Kenvue Says Kenvue Cares Week Volunteer Program Logs 7,750 Hours in 2026 Healthy Lives Mission Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2662482227","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662482227?lang=en_us&edition=fundamental","pubTime":"2026-08-26 23:19","pubTimestamp":1787757545,"startTime":"0","endTime":"0","summary":"Kenvue says Kenvue Cares Week volunteer program logs 7,750 hours in 2026 Healthy Lives Mission reportKenvue highlighted a sustainable innovation push led by Principal Sustainable Innovation Scientist ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLbkgBRW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","RSPS","IE00BFXG1179.USD","LU0889566641.SGD","LU1267930813.SGD","IE00B3T34201.USD","LU0310800379.SGD","LU1267930573.SGD","BK4585","KVUE","BK4183","LU0792757196.USD","LU0128525929.USD","LU0708994859.HKD","LU0029864427.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662153387","title":"Gubra Earns USD 50 Million Milestone as AbbVie Starts Phase 2 Trial of Obesity Drug ABBV-295","url":"https://stock-news.laohu8.com/highlight/detail?id=2662153387","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662153387?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:24","pubTimestamp":1787743481,"startTime":"0","endTime":"0","summary":"Gubra earns USD 50 million milestone as AbbVie starts Phase 2 trial of obesity drug ABBV-295Gubra disclosed AbbVie has started a Phase 2 trial of obesity drug candidate ABBV-295, triggering a USD 50 m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLbnPkf4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0726765562.USD","RXL","LU0472753341.HKD","IE00BVYPNV92.GBP","BK4139","IYH","LU1934455194.USD","LU0122379950.USD","IE00B2B36J28.USD","LU0310800379.SGD","LU2023251221.USD","MEDX","XLV","LU1983299246.USD","IE00B4R5TH58.HKD","LU0965509283.SGD","LU1162221912.USD","LU1430594728.SGD","LU2237443622.USD","LU0820561818.USD","LU2347655156.SGD","LU0029864427.USD","IE00BFTCPJ56.SGD","TRUH","GLAM","FTXH","LU0689472784.USD","PPH","JDOC","IE00B42XCP33.USD","VHT","LU0211328371.USD","LU1244550494.USD","IXJ","LU1670627923.USD","LU1934455863.HKD","LU0198837287.USD","IE00BLSP4452.SGD","IE000SO60NU8.SGD","LU2468319806.SGD","ABBV","LU1923622614.USD","LU1244550577.SGD","BK4566","LU0128525929.USD","LU1244550221.USD","PJP","FHLC","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797145","title":"Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797145","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797145?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:18","pubTimestamp":1787739506,"startTime":"0","endTime":"0","summary":"Uni-Bio Science H1 revenue falls 12% on pricing changesOverviewHong Kong-listed biopharma firm's H1 2026 revenue fell 12% yr/yr amid pricing adjustmentsNet profit dropped 59% as R+D and commercializat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211328371.USD","KURE","BK1191","LU0234572021.USD","00690","LU0211327993.USD","FHLC","IE0002270589.USD","ABBV","LU0868494708.USD","01801","TRUH","LU2129689605.HKD","IE00BSNM7G36.USD","LU0203345920.USD","LU2133065610.SGD","LU0122379950.USD","BK1583","IE0009355771.USD","IE00B2B36J28.USD","JDOC","PPH","VHT","BK4581","AGNG","LU1934455277.USD","MEDX","IYH","PJP","LU0985320562.USD","BK4588","BK4533","IXJ","XLV","LU0057025933.USD","LU1989772840.SGD","RXL","688331","FTXH","LU0820561909.HKD","GLAM","LU2347655073.USD","IE000BZT7R73.USD","IE000MB6IJN5.SGD","03692","LU0203347892.USD","IE00BLSP4452.SGD","IE000WAW04H5.SGD","IE00B19Z3581.USD","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662750377","title":"How GLP-1 Sales Could Play Out for Hims & Hers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662750377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662750377?lang=en_us&edition=fundamental","pubTime":"2026-08-26 06:23","pubTimestamp":1787696580,"startTime":"0","endTime":"0","summary":"Hims & Hers Health is retooling its core weight-loss business this year, shifting from sales of compounded GLP-1 drugs to branded versions of the blockbuster medications.A new analysis from Truist Sec","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THNR","HMYY","HIYY","HEAL","BK4196","HIMY","HIMZ","HIMS","GLAM","HIMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662962752","title":"Analysts Offer Insights on Consumer Goods Companies: The Estée Lauder Companies (EL) and Simply Good Foods (SMPL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662962752","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662962752?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:30","pubTimestamp":1787689817,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on The Estée Lauder Companies (EL) and Simply Good Foods (SMPL)....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-the-estee-lauder-companies-el-and-simply-good-foods-smpl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-goods-companies-the-estee-lauder-companies-el-and-simply-good-foods-smpl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLAM","LU2404859741.USD","BK4588","BK4548","LU2211817866.USD","EL","LU2552382215.SGD","LU0690374961.EUR","LU2404859667.USD","BK4183","BK4504","LU2552382132.HKD","BK4533","BK4212","SMPL","LU2264538146.SGD","LU0690374615.EUR","BK4558","LU1988902786.USD","LU2552382058.USD","LU1064131342.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662755064","title":"Estée Lauder Exec VP, General Counsel Rashida La Lande Sells 5,564 Shares for $553,695.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2662755064","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662755064?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:00","pubTimestamp":1787673611,"startTime":"0","endTime":"0","summary":"Estée Lauder Exec VP, General Counsel Rashida La Lande sells 5,564 shares for $553,695.4Estée Lauder Exec VP and General Counsel Rashida La Lande exercised stock options for 5,564 Class A common share","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nNDL6MFzJG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Estée Lauder Exec VP, General Counsel Rashida La Lande Sells 5,564 Shares for $553,695.4","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0690374961.EUR","LU2404859741.USD","LU2552382132.HKD","LU2552382058.USD","LU2552382215.SGD","BK4548","LU1064131342.USD","LU2404859667.USD","BK4533","BK4183","BK4585","BK4558","BK4504","EL","LU0690374615.EUR","LU2264538146.SGD","GLAM","BK4588","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662320987","title":"China's Shandong Xinhua Profit Drops on Domestic, International Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=2662320987","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662320987?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:59","pubTimestamp":1787662743,"startTime":"0","endTime":"0","summary":"China's Shandong Xinhua profit drops on domestic, international competitionOverviewChina pharmaceutical maker's operating revenue fell 6% yr/yr for six months ended June 2026Net profit attributable to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL1N44M0DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTXH","LU2129689514.USD","BK4550","XLV","LU2237443895.HKD","JDOC","LU0203347892.USD","FHLC","LU1236620750.USD","IE00B19Z3581.USD","IXJ","LU1983299246.USD","PJP","AGNG","GLAM","LU0395794307.EUR","LU1551013342.USD","LU2237443465.HKD","LU2433249047.HKD","688331","LU0289961442.SGD","LU0882574055.USD","LU2148510915.USD","RXL","LU2237443382.USD","MEDX","LU0823416689.USD","IYH","LU1923622614.USD","LU0098860793.USD","LU0057025933.USD","LU0198837287.USD","LU0820561818.USD","LU0289739699.SGD","TRUH","01167","IE0002270589.USD","PPH","VHT","00719","LU1061106388.HKD","IE0000B7K699.USD","LU0943347566.SGD","LU0320765646.SGD","000756","ABBV","BK4139","BK4559","LU0432979614.USD","BK0164"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}